{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:53:28Z","timestamp":1794027208865,"version":"4.8.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T00:00:00Z","timestamp":1605398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"National Megaproject on Key Infectious Diseases","award":["2017ZX10202102"],"award-info":[{"award-number":["2017ZX10202102"]}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","award":["18JCZDJC34400"],"award-info":[{"award-number":["18JCZDJC34400"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2016-I2M-1\u2013017"],"award-info":[{"award-number":["2016-I2M-1\u2013017"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81900182"],"award-info":[{"award-number":["81900182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Pseudomonas aeruginosa (PA) bloodstream infection (BSI) is a common complication in patients with acute leukemia (AL), and the prevalence of antibiotic-resistant strains poses a serious problem. However, there is limited information regarding antibiotic resistance, clinical characteristics, and outcomes of PA BSI in AL patients. This study explored characteristics associated with the clinical outcomes of AL patients with PA BSI and analyzed factors associated with BSI caused by multidrug-resistant (MDR) or carbapenem-resistant strains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This single-center retrospective study enrolled hospitalized AL patients who developed PA BSI during January 2014\u2013December 2019. The Kaplan-Meier method was used to plot survival curves. Multivariate logistic regression analyses were also performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 293 eligible patients with PA BSI, 55 (18.8%) received inappropriate empirical antibiotic therapy within 48 hours of BSI onset, whereas up to 65.8% MDR-PA BSI patients received inappropriate empirical treatment. The 30-day mortality rate was 8.5% for all patients. However, the 30-day mortality rates were 28.9% and 5.5% in MDR-PA BSI and non\u2013MDR-PA BSI patients, respectively (P\u2005&amp;lt;\u2005.001). On multivariate analysis, previous use of quinolones (odds ratio [OR], 5.851 [95% confidence interval {CI}, 2.638\u201312.975]) and piperacillin\/tazobactam (OR, 2.837 [95% CI, 1.151\u20136.994]) were independently associated with MDR-PA BSI; and MDR-PA BSI (OR, 7.196 [95% CI, 2.773\u201318.668]), perianal infection (OR, 4.079 [95% CI, 1.401\u201311.879]), pulmonary infection (OR, 3.028 [95% CI, 1.231\u20137.446]), and age \u226555 years (OR, 2.871 [95% CI, 1.057\u20137.799]) were independent risk factors for 30-day mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>MDR increases mortality risk in PA BSI patients, and previous antibiotic exposure is important in MDR-PA BSI development. Rational antibiotic use based on local antimicrobial susceptibility and clinical characteristics can help reduce antibiotic resistance and mortality.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciaa1522","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T11:12:36Z","timestamp":1601723556000},"page":"S386-S393","source":"Crossref","is-referenced-by-count":61,"title":["Risk Factors and Outcomes of Antibiotic-resistant <i>Pseudomonas aeruginosa<\/i> Bloodstream Infection in Adult Patients With Acute Leukemia"],"prefix":"10.1093","volume":"71","author":[{"given":"Yuanqi","family":"Zhao","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Lin","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhi","family":"Ma","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyan","family":"Shen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Zhu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erlie","family":"Jiang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchang","family":"Mi","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingzhe","family":"Han","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizhou","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,23]]},"reference":[{"key":"2020122314492999100_CIT0001","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1080\/10428194.2016.1193859","article-title":"The growing threat of multidrug-resistant gram-negative infections in patients with hematologic malignancies","volume":"57","author":"Baker","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"2020122314492999100_CIT0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1469-0691.2005.01298.x","article-title":"Risk of bacteraemia and mortality in patients with haematological malignancies","volume":"12","author":"N\u00f8rgaard","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2020122314492999100_CIT0003","doi-asserted-by":"crossref","first-page":"e13186","DOI":"10.1111\/tid.13186","article-title":"Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study","volume":"21","author":"Kern","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"2020122314492999100_CIT0004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1089\/mdr.2015.0220","article-title":"Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options","volume":"22","author":"Cerceo","year":"2016","journal-title":"Microb Drug Resist"},{"key":"2020122314492999100_CIT0005","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1378\/chest.14-2171","article-title":"Antimicrobial resistance in hospital-acquired gram-negative bacterial infections","volume":"147","author":"Mehrad","year":"2015","journal-title":"Chest"},{"key":"2020122314492999100_CIT0006","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5492\/wjccm.v5.i2.111","article-title":"Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients","volume":"5","author":"Paramythiotou","year":"2016","journal-title":"World J Crit Care Med"},{"key":"2020122314492999100_CIT0007","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"2020122314492999100_CIT0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jinf.2017.10.009","article-title":"Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines","volume":"76","author":"Mikulska","year":"2018","journal-title":"J Infect"},{"key":"2020122314492999100_CIT0009","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: a systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"key":"2020122314492999100_CIT0010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/mdr.2010.0170","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome","volume":"17","author":"Joo","year":"2011","journal-title":"Microb Drug Resist"},{"key":"2020122314492999100_CIT0011","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.ijid.2009.11.019","article-title":"Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection","volume":"14","author":"Su\u00e1rez","year":"2010","journal-title":"Int J Infect Dis"},{"key":"2020122314492999100_CIT0012","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1128\/AAC.00750-12","article-title":"Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia","volume":"56","author":"Morata","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2020122314492999100_CIT0013","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.diagmicrobio.2017.05.003","article-title":"Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome","volume":"88","author":"Tofas","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020122314492999100_CIT0014","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/cid\/ciq147","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020122314492999100_CIT0015","first-page":"1068","article-title":"Inappropriate empirical antibiotic treatment in high-risk neutropenic patients with bacteremia in the era of multidrug resistance","volume":"70","author":"Martinez-Nadal","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2020122314492999100_CIT0016","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cmi.2019.07.002","article-title":"Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection","volume":"26","author":"Viasus","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2020122314492999100_CIT0017","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3324\/haematol.2010.036640","article-title":"Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies","volume":"96","author":"Trecarichi","year":"2011","journal-title":"Haematologica"},{"key":"2020122314492999100_CIT0018","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.diagmicrobio.2018.04.012","article-title":"Antimicrobial susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa isolates from United States medical centers stratified by infection type: results from the International Network for Optimal Resistance Monitoring (INFORM) Surveillance Program, 2015\u20132016","volume":"92","author":"Sader","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2020122314492999100_CIT0019","doi-asserted-by":"crossref","first-page":"e02494-19","DOI":"10.1128\/AAC.02494-19","article-title":"Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa","volume":"64","author":"Gudiol","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2020122314492999100_CIT0020","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1093\/cid\/ciy825","article-title":"Fluoroquinolone prophylaxis selects for meropenem-nonsusceptible Pseudomonas aeruginosa in patients with hematologic malignancies and hematopoietic cell transplant recipients","volume":"68","author":"Hakki","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2020122314492999100_CIT0021","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s15010-014-0635-z","article-title":"Characteristics, risk factors and outcomes of adult cancer patients with extensively drug-resistant Pseudomonas aeruginosa infections","volume":"42","author":"Samonis","year":"2014","journal-title":"Infection"},{"key":"2020122314492999100_CIT0022","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhin.2012.10.005","article-title":"Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa","volume":"83","author":"Nakamura","year":"2013","journal-title":"J Hosp Infect"},{"key":"2020122314492999100_CIT0023","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jgar.2018.02.005","article-title":"Risk factors for Pseudomonas aeruginosa infections in Asia-Pacific and consequences of inappropriate initial antimicrobial therapy: a systematic literature review and meta-analysis","volume":"14","author":"Merchant","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"2020122314492999100_CIT0024","doi-asserted-by":"crossref","first-page":"e60624","DOI":"10.1371\/journal.pone.0060624","article-title":"Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"2020122314492999100_CIT0025","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-100-4-515","article-title":"Perirectal infections in acute leukemia. Improved survival after incision and debridement","volume":"100","author":"Barnes","year":"1984","journal-title":"Ann Intern Med"},{"key":"2020122314492999100_CIT0026","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0924-8579(00)00241-7","article-title":"Unusual presentations of infection in neutropenic patients","volume":"16","author":"Bodey","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"2020122314492999100_CIT0027","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/jac\/dkv228","article-title":"In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure","volume":"70","author":"Sol\u00e9","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2020122314492999100_CIT0028","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1038\/emi.2016.22","article-title":"Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies","volume":"5","author":"Zhang","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"2020122314492999100_CIT0029","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/infdis\/jiw299","article-title":"Host and pathogen biomarkers for severe Pseudomonas aeruginosa infections","volume":"215","author":"Juan","year":"2017","journal-title":"J Infect Dis"},{"key":"2020122314492999100_CIT0030","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00277-014-2086-0","article-title":"Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO)","volume":"93","author":"Penack","year":"2014","journal-title":"Ann Hematol"},{"key":"2020122314492999100_CIT0031","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2334-14-161","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy","volume":"14","author":"Kim","year":"2014","journal-title":"BMC Infect Dis"},{"key":"2020122314492999100_CIT0032","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijantimicag.2013.09.002","article-title":"Combination antibiotic therapy versus monotherapy for Pseudomonas aeruginosa bacteraemia: a meta-analysis of retrospective and prospective studies","volume":"42","author":"Hu","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2020122314492999100_CIT0033","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/cid\/cit223","article-title":"Effect of adequate single-drug vs combination antimicrobial therapy on mortality in Pseudomonas aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort","volume":"57","author":"Pe\u00f1a","year":"2013","journal-title":"Clin Infect Dis"},{"key":"2020122314492999100_CIT0034","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2012.12.006","article-title":"Beta-lactam plus aminoglycoside or fluoroquinolone combination versus beta-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis","volume":"41","author":"Vardakas","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"2020122314492999100_CIT0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1080\/23744235.2017.1411605","article-title":"Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains","volume":"50","author":"McCarthy","year":"2018","journal-title":"Infect Dis (Lond)"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_4\/S386\/35098908\/ciaa1522.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/71\/Supplement_4\/S386\/35098908\/ciaa1522.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T19:50:23Z","timestamp":1608753023000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/71\/Supplement_4\/S386\/6046206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,15]]},"references-count":35,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2020,12,23]]},"published-print":{"date-parts":[[2020,12,23]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1522","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11,15]]},"published":{"date-parts":[[2020,11,15]]}}}